P-glycoprotein (MDR1/ABCB1) restricts brain accumulation and Cytochrome P450-3A (CYP3A) limits oral availability of the novel ALK/ROS1 inhibitor lorlatinib.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Alfred H Schinkel Jos Beijnen |
| Publication date | July 10, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |